SEARCH

SEARCH BY CITATION

References

  • 1
    Simmonds, P., Bukh, J., Combet, C., Deleage, G., Enomoto, N., Feinstone, S., Halfon, P. et al., Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005. 42: 962973.
  • 2
    Wieland, S. F. and Chisari, F. V., Stealth and cunning: hepatitis B and hepatitis C viruses. J. Virol. 2005. 79: 93699380.
  • 3
    WHO, Fact sheet No164 Weekly Epidemiological Record. No 49, 10 December 1999. http://www.who.int/docstore/wer/pdf/1999/wer7449.pdf.
  • 4
    Diepolder, H. M., Zachoval, R., Hoffmann, R. M., Wierenga, E. A., Santantonio, T., Jung, M. C., Eichenlaub, D. and Pape, G. R., Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995. 346: 10061007.
  • 5
    Lechner, F., Wong, D. K., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G. et al., Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 2000. 191: 14991512.
  • 6
    Thimme, R., Oldach, D., Chang, K. M., Steiger, C., Ray, S. C. and Chisari, F. V., Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 2001. 194: 13951406.
  • 7
    Klenerman, P. and Hill, A., T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 2005. 6: 873879.
  • 8
    Shoukry, N. H., Grakoui, A., Houghton, M., Chien, D. Y., Ghrayeb, J., Reimann, K. A. and Walker, C. M., Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 2003. 197: 16451655.
  • 9
    Deignan, T., Curry, M. P., Doherty, D. G., Golden-Mason, L., Volkov, Y., Norris, S., Nolan, N. et al., Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection. J. Hepatol. 2002. 37: 101108.
  • 10
    Durante-Mangoni, E., Wang, R., Shaulov, A., He, Q., Nasser, I., Afdhal, N., Koziel, M. J. and Exley, M. A., Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. J. Immunol. 2004. 173: 21592166.
  • 11
    Nascimbeni, M., Pol, S. and Saunier, B., Distinct CD4CD8 double-positive T cells in the blood and liver of patients during chronic hepatitis B and C. PLoS One 2011. 6: e20145.
  • 12
    Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R. and Ahmed, R., Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 2003. 77: 49114927.
  • 13
    Kasprowicz, V., Schulze Zur Wiesch, J., Kuntzen, T., Nolan, B. E., Longworth, S., Berical, A., Blum, J. et al., High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. J. Virol. 2008. 82: 31543160.
  • 14
    Radziewicz, H., Ibegbu, C. C., Fernandez, M. L., Workowski, K. A., Obideen, K., Wehbi, M., Hanson, H. L. et al., Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. 2007. 81: 25452553.
  • 15
    Rigopoulou, E. I., Abbott, W. G., Haigh, P. and Naoumov, N. V., Blocking of interleukin-10 receptor – a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus. Clin. Immunol. 2005. 117: 5764.
  • 16
    Thimme, R., Bukh, J., Spangenberg, H. C., Wieland, S., Pemberton, J., Steiger, C., Govindarajan, S. et al., Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc. Natl. Acad. Sci. USA 2002. 99: 1566115668.
  • 17
    Grakoui, A., Shoukry, N. H., Woollard, D. J., Han, J. H., Hanson, H. L., Ghrayeb, J., Murthy, K. K. et al., HCV persistence and immune evasion in the absence of memory T cell help. Science 2003. 302: 659662.
  • 18
    Missale, G., Bertoni, R., Lamonaca, V., Valli, A., Massari, M., Mori, C., Rumi, M. G. et al., Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Invest. 1996. 98: 706714.
  • 19
    Gerlach, J. T., Diepolder, H. M., Jung, M. C., Gruener, N. H., Schraut, W. W., Zachoval, R., Hoffmann, R. et al., Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999. 117: 933941.
  • 20
    Rosen, H. R., Miner, C., Sasaki, A. W., Lewinsohn, D. M., Conrad, A. J., Bakke, A., Bouwer, H. G. and Hinrichs, D. J., Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology 2002. 35: 190198.
  • 21
    Day, C. L., Lauer, G. M., Robbins, G. K., McGovern, B., Wurcel, A. G., Gandhi, R. T., Chung, R. T. and Walker, B. D., Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J. Virol. 2002. 76: 1258412595.
  • 22
    Urbani, S., Amadei, B., Fisicaro, P., Tola, D., Orlandini, A., Sacchelli, L., Mori, C. et al., Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 2006. 44: 126139.
  • 23
    Tsai, S. L., Liaw, Y. F., Chen, M. H., Huang, C. Y. and Kuo, G. C., Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology 1997. 25: 449458.
  • 24
    Folgori, A., Spada, E., Pezzanera, M., Ruggeri, L., Mele, A., Garbuglia, A. R., Perrone, M. P. et al., Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance. Gut 2006. 55: 10121019.
  • 25
    Ulsenheimer, A., Gerlach, J. T., Gruener, N. H., Jung, M. C., Schirren, C. A., Schraut, W., Zachoval, R. et al., Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology 2003. 37: 11891198.
  • 26
    Semmo, N., Day, C. L., Ward, S. M., Lucas, M., Harcourt, G., Loughry, A. and Klenerman, P., Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 2005. 41: 10191028.
  • 27
    Jo, J., Aichele, U., Kersting, N., Klein, R., Aichele, P., Bisse, E., Sewell, A. K. et al., Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model. Gastroenterology 2009. 136: 13911401.
  • 28
    Cooper, S., Erickson, A. L., Adams, E. J., Kansopon, J., Weiner, A. J., Chien, D. Y., Houghton, M. et al., Analysis of a successful immune response against hepatitis C virus. Immunity 1999. 10: 439449.
  • 29
    Gruener, N. H., Lechner, F., Jung, M. C., Diepolder, H., Gerlach, T., Lauer, G., Walker, B. et al., Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J. Virol. 2001. 75: 55505558.
  • 30
    Urbani, S., Boni, C., Missale, G., Elia, G., Cavallo, C., Massari, M., Raimondo, G. and Ferrari, C., Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J. Virol. 2002. 76: 1242312434.
  • 31
    Shoukry, N. H., Cawthon, A. G. and Walker, C. M., Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu. Rev. Microbiol. 2004. 58: 391424.
  • 32
    Cox, A. L., Mosbruger, T., Mao, Q., Liu, Z., Wang, X. H., Yang, H. C., Sidney, J. et al., Cellular immune selection with hepatitis C virus persistence in humans. J. Exp. Med. 2005. 201: 17411752.
  • 33
    Cucchiarini, M., Kammer, A. R., Grabscheid, B., Diepolder, H. M., Gerlach, T. J., Gruner, N., Santantonio, T. et al., Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection. Cell Immunol. 2000. 203: 111123.
  • 34
    Lauer, G. M., Barnes, E., Lucas, M., Timm, J., Ouchi, K., Kim, A. Y., Day, C. L. et al., High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 2004. 127: 924936.
  • 35
    Wong, D. K., Dudley, D. D., Afdhal, N. H., Dienstag, J., Rice, C. M., Wang, L., Houghton, M. et al., Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J. Immunol. 1998. 160: 14791488.
  • 36
    Erickson, A. L., Kimura, Y., Igarashi, S., Eichelberger, J., Houghton, M., Sidney, J., McKinney, D. et al., The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 2001. 15: 883895.
  • 37
    Neumann-Haefelin, C., McKiernan, S., Ward, S., Viazov, S., Spangenberg, H. C., Killinger, T., Baumert, T. F. et al., Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology 2006. 43: 563572.
  • 38
    Bowen, D. G. and Walker, C. M., Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005. 436: 946952.
  • 39
    Rehermann, B. and Nascimbeni, M., Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 2005. 5: 215229.
  • 40
    Meyer-Olson, D., Shoukry, N. H., Brady, K. W., Kim, H., Olson, D. P., Hartman, K., Shintani, A. K. et al., Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J. Exp. Med. 2004. 200: 307319.
  • 41
    Timm, J., Lauer, G. M., Kavanagh, D. G., Sheridan, I., Kim, A. Y., Lucas, M., Pillay, T. et al., CD8 epitope escape and reversion in acute HCV infection. J. Exp. Med. 2004. 200: 15931604.
  • 42
    Seifert, U., Liermann, H., Racanelli, V., Halenius, A., Wiese, M., Wedemeyer, H., Ruppert, T. et al., Hepatitis C virus mutation affects proteasomal epitope processing. J. Clin. Invest. 2004. 114: 250259.
  • 43
    Neumann-Haefelin, C., Timm, J., Spangenberg, H. C., Wischniowski, N., Nazarova, N., Kersting, N., Roggendorf, M. et al., Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection. Hepatology 2008. 47: 18241836.
  • 44
    Chang, K. M., Rehermann, B., McHutchison, J. G., Pasquinelli, C., Southwood, S., Sette, A. and Chisari, F. V., Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J. Clin. Invest. 1997. 100: 23762385.
  • 45
    Tester, I., Smyk-Pearson, S., Wang, P., Wertheimer, A., Yao, E., Lewinsohn, D. M., Tavis, J. E. and Rosen, H. R., Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J. Exp. Med. 2005. 201: 17251731.
  • 46
    Soderholm, J., Ahlen, G., Kaul, A., Frelin, L., Alheim, M., Barnfield, C., Liljestrom, P. et al., Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut 2006. 55: 266274.
  • 47
    Friedrich, T. C., Dodds, E. J., Yant, L. J., Vojnov, L., Rudersdorf, R., Cullen, C., Evans, D. T. et al., Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat. Med. 2004. 10: 275281.
  • 48
    Ray, S. C., Fanning, L., Wang, X. H., Netski, D. M., Kenny-Walsh, E. and Thomas, D. L., Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J. Exp. Med. 2005. 201: 17531759.
  • 49
    Salloum, S., Oniangue-Ndza, C., Neumann-Haefelin, C., Hudson, L., Giugliano, S., Aus dem Siepen, M., Nattermann, J. et al., Escape from HLA-B*08 restricted CD8 T cells by hepatitis C virus is associated with fitness costs. J. Virol. 2008. 136: 1180311812.
  • 50
    Fitzmaurice, K., Petrovic, D., Ramamurthy, N., Simmons, R., Merani, S., Gaudieri, S., Sims, S. et al., Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection. Gut 2011. 60: 15631571.
  • 51
    Dazert, E., Neumann-Haefelin, C., Bressanelli, S., Fitzmaurice, K., Kort, J., Timm, J., McKiernan, S. et al., Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. J. Clin. Invest. 2009. 119: 376386.
  • 52
    Uebelhoer, L., Han, J. H., Callendret, B., Mateu, G., Shoukry, N. H., Hanson, H., Rice, C. M. et al., Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness. PLoS Pathog. 2008. 4: e1000143.
  • 53
    Klenerman, P. and Zinkernagel, R. M., Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 1998. 394: 482485.
  • 54
    Gaudieri, S., Rauch, A., Park, L. P., Freitas, E., Herrmann, S., Jeffrey, G., Cheng, W. et al., Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J. Virol. 2006. 80: 1109411104.
  • 55
    Salloum, S., Kluge, S. F., Kim, A. Y., Roggendorf, M. and Timm, J., The resistance mutation R155K in the NS3/4A protease of hepatitis C virus also leads the virus to escape from HLA-A*68-restricted CD8 T cells. Antiviral Res. 2010. 87: 272275.
  • 56
    Ruhl, M., Knuschke, T., Schewior, K., Glavinic, L., Neumann-Haefelin, C., Chang, D. I., Klein, M. et al., The CD8+ T-cell response promotes evolution of hepatitis C viris nonstructural proteins. Gastroenterology 2011. 140: 20642073.
  • 57
    Neumann-Haefelin, C., Frick, D. N., Wang, J. J., Pybus, O. G., Salloum, S., Narula, G. S., Eckart, A. et al., Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level. J. Virol. 2008. 82: 34383451.
  • 58
    Timm, J., Li, B., Daniels, M. G., Bhattacharya, T., Reyor, L. L., Allgaier, R., Kuntzen, T., Fischer, W. et al., Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. Hepatology 2007. 46: 339349.
  • 59
    Kim, A. Y., Kuntzen, T., Timm, J., Nolan, B. E., Baca, M. A., Reyor, L. L., Berical, A. C. et al., Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. Gastroenterology 2011. 140: 686696.
  • 60
    Rauch, A., James, I., Pfafferott, K., Nolan, D., Klenerman, P., Cheng, W., Mollison, L. et al., Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology 2009. 49: 10691082.
  • 61
    McKiernan, S. M., Hagan, R., Curry, M., McDonald, G. S., Kelly, A., Nolan, N., Walsh, A. et al., Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 2004. 40: 108114.
  • 62
    Wang, H. and Eckels, D. D., Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. J. Immunol. 1999. 162: 41774183.
  • 63
    Wang, J. H., Layden, T. J. and Eckels, D. D., Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response. Hum. Immunol. 2003. 64: 662673.
  • 64
    Penna, A., Missale, G., Lamonaca, V., Pilli, M., Mori, C., Zanelli, P., Cavalli, A. et al., Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C. Hepatology 2002. 35: 12251236.
  • 65
    Fleming, V. M., Harcourt, G., Barnes, E. and Klenerman, P., Virological footprint of CD4+ T-cell responses during chronic hepatitus C virus infection. J. Gen. Virol. 2010. 91: 13961406.
  • 66
    Fuller, M. J., Shoukry, N. H., Gushima, T., Bowen, D. G., Callendret, B., Campbell, K. J. et al., Cell responses in persistent hepatitis C virus infection. Hepatology 2010. 51: 378387.
  • 67
    Petrovic, D., Stamataki, Z., Dempsey, E., Golden-Mason, L., Freeley, M., Doherty, D., Prichard, D. et al., Hepatitis C virus targets the T cell secretory machinery as a mechanism of immune evasion. Hepatology 2011. 53: 18461853.
  • 68
    Frasca, L., Del Porto, P., Tuosto, L., Marinari, B., Scotta, C., Carbonari, M., Nicosia, A. and Piccolella, E., Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells. J. Immunol. 1999. 163: 650658.
  • 69
    Pircher, H., Moskophidis, D., Rohrer, U., Bürki, K., Hengartner, H. and Zinkernagel, R. M., Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 1990. 346: 629633.
  • 70
    Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G., et al., Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991. 354: 453459.
  • 71
    Dring, M. M., Morrison, M. H., McSharry, B. P., Guinan, K. J., Hagan, R., Irish HCV Research Consortium, O'Farrelly, C. et al., Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 2011. 108: 57365741: 5736–5741.
  • 72
    Goulder, P. J., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P. et al., Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 1997. 3: 212217.
  • 73
    McMichael, A. and Klenerman, P., HIV/AIDS. HLA leaves its footprints on HIV. Science 2002. 296: 14101411.
  • 74
    Moore, C. B., John, M., James, I. R., Christiansen, F. T., Witt, C. S. and Mallal, S. A., Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002. 296: 14391443.
  • 75
    Pfafferott, K., Gaudieri, S., Ulsenheimer, A., James, I., Heeg, M., Nolan, D., John, M. et al., Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity. PLos One 2011. 6: e16797.
  • 76
    O'Connor, D. H., McDermott, A. B., Krebs, K. C., Dodds, E. J., Miller, J. E., Gonzalez, E. J., Jacoby, T. J. et al., A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation. J. Virol. 2004. 78: 1401214022.
  • 77
    Allen, T. M., Yu, X. G., Kalife, E. T., Reyor, L. L., Lichterfeld, M., John, M., Cheng, M. et al., De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J. Virol. 2005. 79: 1295212960.
  • 78
    Kuntzen, T., Timm, J., Berical, A., Lewis-Ximenez, L., Jones, A., Nolan, B., Schulze zur Wiesch, J. et al., Viral sequence evolution in acute hepatitis C virus infection. J. Virol. 2007. 81: 1165811668.
  • 79
    Schneidewind, A., Brockman, M. A., Yang, R., Adam, R. I., Li, B., Le Gall, S., Rinaldo, C. R. et al., Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J. Virol. 2007. 81: 1238212393.
  • 80
    Leslie, A. J., Pfafferott, K. J., Chetty, P., Draenert, R., Addo, M. M., Feeney, M., Tang, Y. et al., HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 2004. 10: 282289.
  • 81
    Kelleher, A. D., Long, C., Holmes, E. C., Allen, R. L., Wilson, J., Conlon, C., Workman, C. et al., Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med. 2001. 193: 375386.
  • 82
    Feeney, M. E., Tang, Y., Roosevelt, K. A., Leslie, A. J., McIntosh, K., Karthas, N., Walker, B. D. and Goulder, P. J., Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J. Virol. 2004. 78: 89278930.
  • 83
    Brockman, M. A., Schneidewind, A., Lahaie, M., Schmidt, A., Miura, T., Desouza, I., Ryvkin, F. et al., Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J. Virol. 2007. 81: 1260812618.
  • 84
    Crawford, H., Prado, J. G., Leslie, A., Hué, S., Honeyborne, I., Reddy, S., van der Stok, M. et al., Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. J. Virol. 2007. 81: 83468351.